abstract |
Compound of formula (I) or a pharmaceutically acceptable salt thereof: n n n Among them, R 2 , W, A, Y, and R 1 are as defined in the specification, which are p38 MAPK inhibitors and can be used as anti-inflammatory agents for the treatment of respiratory diseases in particular. |